Over 90 Total Lots Up For Auction at One Location - WA 04/08

Gene associated with sudden cardiac death identified by ICD monitoring

Press releases may be edited for formatting or style | August 31, 2015
London, UK - 31 Aug 2015: A gene associated with sudden cardiac death in the general population has been identified using implantable cardioverter defibrillator (ICD) monitoring in research presented for the first time at ESC Congress today.1 The research included patients from the DISCOVERY trial and Oregon-SUDS and discovered that a polymorphism in the GNAS gene predicted ventricular tachyarrhythmias and sudden cardiac death.

"This is the first time a gene has been identified using ICD monitoring and then confirmed to be associated with sudden cardiac death in the general population," said principal investigator Professor Heiner Wieneke, chief physician in the Department of Cardiology, Contilia Heart and Vessel Centre, St. Marien-Hospital Mülheim, Germany. "Epidemiological studies have suggested that genetic factors contribute to sudden cardiac death but only a few genes have been identified."

Sudden cardiac death is one of the leading causes of death in Western countries and cardiac arrhythmias have been reported as the cause in many cases. Prior clinical studies have suggested that an individual's genes may contribute to the risk of cardiac arrhythmias and sudden cardiac death.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
ICDs are indicated for patients who either have survived a life threatening cardiac arrhythmia or have a high risk for sudden cardiac death due to cardiac arrhythmias. ICDs continuously monitor a patient's cardiac rhythm. They also can diagnose and treat cardiac arrhythmias, potentially preventing sudden cardiac death.

Part one of the study was the DISCOVERY trial, a prospective, international, multicentre study in 1 145 patients who received an ICD for primary prevention of sudden cardiac death. ICDs were used to monitor and store cardiac arrhythmia data to study whether specific genes were associated with an increased risk of potentially life-threatening ventricular tachyarrhythmias. The researchers genotyped seven single nucleotide polymorphisms (SNPs) in three genes (GNB3, GNAQ and GNAS) coding G-protein subunits.2 G-proteins interact with stimulated adrenoreceptors, angiotensin II receptors and ion channels in myocardial cells. Abnormal G-protein signal transduction has been suggested as a mechanism contributing to sudden cardiac death.

In the second part of the study, the genes found to be associated with cardiac arrhythmias in the DISCOVERY trial were evaluated in 1 335 patients from Oregon-SUDS (Sudden Unexpected Death Study), a community-based study analysing causes of sudden cardiac death in the Portland, Oregon metropolitan area.3

You Must Be Logged In To Post A Comment